This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$119.00
only $9.15 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Zecic, A. et al. Lactic acidosis in a newborn with adrenal calcifications. Pediatr. Res. 66, 317–322 (2009).
Meyer-Schuman, R. & Antonellis, A. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease. Hum. Mol. Genet. 26, R114–R127 (2017).
Pierce, S. B. et al. Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrault syndrome. Am. J. Hum. Genet. 92, 614–620 (2013).
Riley, L. G. et al. LARS2 variants associated with hydrops, lactic acidosis, sideroblastic anemia, and multisystem failure. JIMD Rep. 28, 19–57 (2016).
Solda, G. et al. First independent replication of the involvement of LARS2 in Perrault syndrome by whole-exome sequencing of an Italian family. J. Hum. Genet. 61, 295–300 (2016).
Lerat, J. et al. An application of NGS for molecular investigations in Perrault syndrome: study of 14 families and review of the literature. Hum. Genet. 37, 1354–1362 (2016).
Demain, L. A. M. et al. Expanding the genotype spectrum of Perrault syndrome. Clin. Genet. 91, 302–312 (2017).
Kosaki, R., Horikawa, R., Fujii, E. & Kosaki, K. Biallelic mutations in LARS2 can cause Perrault syndrome type 2 with neurologic symptoms. Am. J. Med. Genet. 176, 404–408 (2018).
van der Knaap, M. S. et al. Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy. Neurology 92, 1225–1236 (2019).
Carminho-Rodrigues, M. T. et al. LARS2-Perrault syndrome: a new case report and literature review. BMC Med. Genet. 21, e109 (2020).
Riley, L. G. et al. The expanding LARS2 phenotypic spectrum: HLASA, Perrault syndrome with leukodystrophy, and mitochondrial myopathy. Hum. Mutat. 41, 1425–1434 (2020).
Pan, Z. et al. Perrault syndrome: clinical report and retrospective analysis. Mol. Genet. Genom. Med. 8, e1445 (2020).
Buonfiglio, P. I. et al. Predicting pathogenicity for novel hearing loss mutations based on genetic and protein structure approaches. Sci. Rep. 12, e301 (2022).
Schwarz, J. M., Cooper, D. N., Schuelke, M. & Seelow, D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat. Methods 11, 361–362 (2014).
Author information
Authors and Affiliations
Contributions
Conceptualization and data curation: B.D.P., J.S., R.K. and A.V.; formal analysis and methodology: A.V., R.V.C. and H.P.; project administration, resources and supervision: R.V.C. and A.V.; manuscript draft preparation: B.D.P.; review, editing and approval of the final version: all authors.
Corresponding author
Ethics declarations
Competing interests
R.V.C. and A.V. are members of the European Reference Network for Hereditary Metabolic Disorders, MetabERN. The remaining authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Paepe, B., Smet, J., Kopajtich, R. et al. Neonatal lactic acidosis explained by LARS2 defect. Pediatr Res (2022). https://doi.org/10.1038/s41390-022-02169-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41390-022-02169-7